Hyperuricemia and cardiovascular disease in patients with hypertension

Connecticut Medicine

Volumn 80, Issue 2, 2016, Pages 85-90

  Acevedo, Andres ^a   Benavides, Julian ^a   Chowdhury, Mohsin ^b   Lopez, Mabel ^a   Pena, Laura ^a   Montenegro, Ana ^a   Lievano, Marta ^c   Lombo, Bernardo ^b  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

Author keywords

Coronary heart disease; Hyperuricemia; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

AGED; BLOOD; BODY MASS; CARDIOVASCULAR DISEASES; COLOMBIA; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; HYPERURICEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE; PREVALENCE; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

AGED; BIOMARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COLOMBIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERURICEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES; URIC ACID;

EID: 84960907730     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008; 359(17): 1811-21.
2. Talaat KM, el-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol. 2007; 27(5): 435-40.
3. Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis. 2009; 202(1): 11-7.
4. Cannon PJ, Stason WB, Demartini FE, et al. Hyperuricemia in primary and renal hypertension. N Engl J Med. 1966; 275(9): 457-64.
5. Ford ES, Li C, Cook S, et al. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007; 115(19): 2526-32.
6. Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol. 2001; 87(12): 1411-4.
7. Sui X, Church TS, Meriwether RA, et al. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 2008; 57(6): 845-52.
8. Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2006; 47(1): 51-9.
9. Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999; 131(1): 7-13.
10. Palmer TM, Nordestgaard BG, Benn M, et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ. 2013; 347: f4262.
11. Moriarity JT, Folsom AR, Iribarren C, et al. Serum uric acid and risk of coronary heart disease: atherosclerosis risk in communities (ARIC) study. Ann Epidemiol. 2000; 10(3): 136-43.
12. Fernando L, Pamela S, Alejandra L. Cardiovascular disease in Latin America: the growing epidemic. Prog Cardiovasc Dis. 2014; 57(3): 262-7.
13. Lombo B, Villalobos C, Tique C, et al. Metabolic syndrome prevalence in patients attending the hypertension clinic at the Fundacion Santa Fe de Bogota. Rev Colomb Cardiol. 2006; 12(7): 472-478.
14. Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health. 2004; 4: 9.
15. Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis. 2007; 17(6): 409-14.
16. Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens. 2007; 25(8): 1583-9.
17. Abbott RD, Brand FN, Kannel WB, et al. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol. 1988; 41(3): 237-42.
18. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987; 82(3): 421-6.
19. Krishnan E, Svendsen K, Neaton JD, et al. Long-Term cardiovascular mortality among middle-Aged men with gout. Arch Intern Med. 2008; 168(10): 1104-10.
20. Ioachimescu AG, Brennan DM, Hoar BM, et al. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 2008; 58(2): 623-30.
21. Grassi D, Ferri L, Desideri G, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des. 2013; 19(13): 2432-8.
22. Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-Aged men: a prospective cohort study. Arch Intern Med. 2004; 164(14): 1546-51.
23. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003; 41(6): 1183-90.
24. Ames BN, Cathcart R, Schwiers E, et al. Uric acid provides an antioxidant defense in humans against oxidant-And radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981; 78(11): 6858-62.
25. Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and risk of stroke: a systematic review and meta-Analysis. Arthritis Rheum. 2009; 61(7): 885-92.
26. Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-Analysis. Arthritis Care Res. 2010; 62(2): 170-80.
27. Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol. 2006; 62(6): 633-44.
28. Hayden MR, Tyagi SC. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab. 2004; 1(1): 10.
29. Sautin YY, Nakagawa T, Zharikov S, et al. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol. 2007; 293(2): C584-96.
30. Roy D, Perreault M, Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol. 1998; 274(4 Pt 1): E692-9.